Skip to main content
. 2014 Jan 9;7(8):1225–1237. doi: 10.1586/14760584.7.8.1225

Table 2. Noteworthy adverse events after smallpox vaccination, USA, December 2002–June 2004.

Event type Events and rates among 628,414 DoD vaccinees*
  Events and rates among 39,566 DHHS vaccinees
Historical rate per million vaccinees
  Events (n) Rate per million DoD vaccinees   Events (n) Rate per million DHHS vaccinees  
Moderate or serious
Postvaccinial encephalitis
1
1.6
 
1
26
2.6–8.7
Acute myopericarditis
83§
132
 
21§
531
100
Eczema vaccinatum
0
0
 
0
0
2–35
Progressive vaccinia
0
0
 
0
0
1–7
Mild or temporary
Generalized vaccinia, mild
40
64
 
3
77
45–212
Erythema multiforme major
1
1.6
 
0
0
NA
Inadvertent inoculation, self
73
116
 
24
607
606
Vaccinia transfer to contact 47 75   0 0 8–27

*Primarily composed of uniformed military personnel plus some DoD civilian employees; a minority of this total was healthcare workers.

Based on adolescent and adult smallpox vaccination from 1968 studies (both primary and revaccination).

§DoD events include four biopsy-confirmed, 73 probable and six suspected cases; DHHS events include none confirmed, five probable and 16 suspected cases.

DoD events include 59 inadvertent inoculations of the skin and 14 of the eye; DHHS events include 21 inadvertent inoculations of the skin and three of the eye.

DoD: Department of Defense; DHHS: Department of Health and Human Services; NA: Not available.

Data from [56,57,60–62,75,106].

HHS Vulnerability Disclosure